These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Effect of steroid pulse therapy with and without orbital radiotherapy on Graves' ophthalmopathy. Ohtsuka K; Sato A; Kawaguchi S; Hashimoto M; Suzuki Y Am J Ophthalmol; 2003 Mar; 135(3):285-90. PubMed ID: 12614743 [TBL] [Abstract][Full Text] [Related]
23. Treatment of Graves' ophthalmopathy by steroid therapy, orbital radiation therapy, plasmapheresis and thyroxine replacement. Yamamoto K; Saito K; Takai T; Yoshida S Endocrinol Jpn; 1982 Aug; 29(4):495-501. PubMed ID: 6897533 [TBL] [Abstract][Full Text] [Related]
24. Big muscles and big nerves. Dabbs CB; Kline LB Surv Ophthalmol; 1997; 42(3):247-54. PubMed ID: 9406370 [TBL] [Abstract][Full Text] [Related]
25. Radiologically manifested accessory extraocular muscles in thyroid eye disease. Sinclair NE; Roberts MA; Hourihan MD; Walters RF; Lane CM Ophthalmic Plast Reconstr Surg; 2010; 26(4):286-8. PubMed ID: 20502362 [TBL] [Abstract][Full Text] [Related]
26. Radiation therapy for Graves' ophthalmopathy: trick or treat? Feldon SE Ophthalmology; 2001 Sep; 108(9):1521-2. PubMed ID: 11535444 [No Abstract] [Full Text] [Related]
27. Radiotherapy in benign orbital disease. II: Ophthalmic Graves' disease and orbital histiocytosis X. Harnett AN; Doughty D; Hirst A; Plowman PN Br J Ophthalmol; 1988 Apr; 72(4):289-92. PubMed ID: 3259894 [TBL] [Abstract][Full Text] [Related]
28. Orbital radiotherapy for Graves' ophthalmopathy: useful or useless? Safe or dangerous? Bartalena L; Marcocci C; Gorman CA; Wiersinga WM; Pinchera A J Endocrinol Invest; 2003 Jan; 26(1):5-16. PubMed ID: 12602528 [TBL] [Abstract][Full Text] [Related]
29. Late recurrence of unilateral graves orbitopathy on the contralateral side. Kalmann R; Mourits MP Am J Ophthalmol; 2002 May; 133(5):727-9. PubMed ID: 11992884 [TBL] [Abstract][Full Text] [Related]
31. The challenge of orbital decompression in a patient with multiple autoimmune diseases and graves' orbitopathy: a case report and review of literature. Sellari-Franceschini S; Bartalena L; Seccia V Orbit; 2010 Feb; 29(1):48-50. PubMed ID: 20302412 [TBL] [Abstract][Full Text] [Related]
32. Ocular neuromyotonia in Graves dysthyroid orbitopathy. Chung SM; Lee AG; Holds JB; Roper-Hall G; Cruz OA Arch Ophthalmol; 1997 Mar; 115(3):365-70. PubMed ID: 9076209 [TBL] [Abstract][Full Text] [Related]
33. Ultrasound in early thyroid orbitopathy. Shammas HJ; Minckler DS; Ogden C Arch Ophthalmol; 1980 Feb; 98(2):277-9. PubMed ID: 6892557 [TBL] [Abstract][Full Text] [Related]
34. The use of orbital radiotherapy for Graves' ophthalmopathy: quantitative review of the evidence. Wei RL; Cheng JW; Cai JP Ophthalmologica; 2008; 222(1):27-31. PubMed ID: 18097177 [TBL] [Abstract][Full Text] [Related]
35. Orbital radiotherapy for Graves' ophthalmopathy. Bartalena L; Marcocci C; Pinchera A J Clin Endocrinol Metab; 2004 Jan; 89(1):13-4. PubMed ID: 14715819 [No Abstract] [Full Text] [Related]
36. [Effects of external orbital radiotherapy on the oculomotor muscle in Graves disease]. Maalouf T; Angioi-Duprez K; Beckendorff V; Malet T; George JL J Fr Ophtalmol; 1996; 19(12):748-54. PubMed ID: 9033899 [TBL] [Abstract][Full Text] [Related]
37. [Possibilities of MR evaluation in thyroid orbitopathy]. Sosnowski P; Stajgis M Przegl Lek; 2004; 61(8):829-32. PubMed ID: 15789908 [TBL] [Abstract][Full Text] [Related]
38. Graves' disease of the orbit. Weber AL; Dallow RL; Sabates NR Neuroimaging Clin N Am; 1996 Feb; 6(1):61-72. PubMed ID: 8919134 [TBL] [Abstract][Full Text] [Related]
39. Prognostic factors in the radiotherapy of Graves' ophthalmopathy. Petersen IA; Kriss JP; McDougall IR; Donaldson SS Int J Radiat Oncol Biol Phys; 1990 Aug; 19(2):259-64. PubMed ID: 2118493 [TBL] [Abstract][Full Text] [Related]